RESUMEN
The vertebrate hindbrain is segmented into rhombomeres (r) initially defined by distinct domains of gene expression. Previous studies have shown that noise-induced gene regulation and cell sorting are critical for the sharpening of rhombomere boundaries, which start out rough in the forming neural plate (NP) and sharpen over time. However, the mechanisms controlling simultaneous formation of multiple rhombomeres and accuracy in their sizes are unclear. We have developed a stochastic multiscale cell-based model that explicitly incorporates dynamic morphogenetic changes (i.e. convergent-extension of the NP), multiple morphogens, and gene regulatory networks to investigate the formation of rhombomeres and their corresponding boundaries in the zebrafish hindbrain. During pattern initiation, the short-range signal, fibroblast growth factor (FGF), works together with the longer-range morphogen, retinoic acid (RA), to specify all of these boundaries and maintain accurately sized segments with sharp boundaries. At later stages of patterning, we show a nonlinear change in the shape of rhombomeres with rapid left-right narrowing of the NP followed by slower dynamics. Rapid initial convergence improves boundary sharpness and segment size by regulating cell sorting and cell fate both independently and coordinately. Overall, multiple morphogens and tissue dynamics synergize to regulate the sizes and boundaries of multiple segments during development.
Asunto(s)
Tipificación del Cuerpo/fisiología , Modelos Biológicos , Pez Cebra/embriología , Animales , Tipificación del Cuerpo/genética , Biología Computacional , Desarrollo Embrionario/genética , Desarrollo Embrionario/fisiología , Factores de Crecimiento de Fibroblastos/fisiología , Regulación del Desarrollo de la Expresión Génica , Sustancias de Crecimiento/fisiología , Rombencéfalo/citología , Rombencéfalo/embriología , Transducción de Señal , Procesos Estocásticos , Tretinoina/fisiología , Pez Cebra/genéticaRESUMEN
Purpose: PACAP1-38, a member of the secretin/glucagon superfamily, is expressed in the developing retina with documented neuroprotective effects. However, its function in retinal cell differentiation has yet to be elucidated. Our goals, therefore, were to identify PAC1 expressing cells morphologically, investigate the PACAP1-38 action functionally, and establish PACAP1-38 regulated events developmentally during the first postnatal week in rat retina. Methods: P1 retinal sections or whole mounts of Wistar rats were used to reveal PAC1 and calbindin immunoreactive structures. P1, P3, or P7 pups were injected intravitreally with 100 pmol PACAP1-38. Tissues were harvested 24 hours post-treatment, then processed for calbindin immunohistochemistry to determine horizontal cell number, or 6, 12, 24 hours post-treatment for real-time PCR and immunoblots to detect PCNA expression. To localize proliferating cells, anti-PCNA antibody was applied. Results: We showed various PAC1 expressing cells in RPE, NBL, and GCL in P1 retina including calbindin positive horizontal cells. We found that PACAP1-38 induced a marked cell number increase at P3 and P7 and showed upregulated cell proliferation as its mechanism; however, it was ineffective at P1. PACAP1-38 induced proliferative cells localized in the NBL, and double-marker studies demonstrated that the induced proliferative cells were horizontal cells. Conclusions: PACAP1-38 appears to act in retinal differentiation by inducing mitosis selectively in a time and cell specific manner through PAC1. The control of horizontal cell proliferation raises the novel possibilities that (1) PACAP1-38 may be a major player in retinal patterning and (2) PACAP signaling may be critical in retinoblastoma.
Asunto(s)
Sustancias de Crecimiento/fisiología , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/fisiología , Retina/crecimiento & desarrollo , Células Horizontales de la Retina/citología , Animales , Western Blotting , Calbindinas/metabolismo , Recuento de Células , Diferenciación Celular , Proliferación Celular , Femenino , Expresión Génica , Masculino , Microscopía Confocal , Ratas , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores del Polipéptido Activador de la Adenilato-Ciclasa Hipofisaria/metabolismo , Retina/metabolismo , Células Horizontales de la Retina/metabolismoRESUMEN
PURPOSE OF REVIEW: The pathogenesis of systemic sclerosis depends on a complex interplay between autoimmunity, vasculopathy, and fibrosis. Reversible phosphorylation on tyrosine residues, in response to growth factors and other stimuli, critically regulates each one of these three key pathogenic processes. Protein tyrosine kinases, the enzymes that catalyze addition of phosphate to tyrosine residues, are known players in systemic sclerosis, and tyrosine kinase inhibitors are undergoing clinical trials for treatment of this disease. Until recently, the role of tyrosine phosphatases-the enzymes that counteract the action of tyrosine kinases by removing phosphate from tyrosine residues-in systemic sclerosis has remained largely unknown. Here, we review the function of tyrosine phosphatases in pathways relevant to the pathogenesis of systemic sclerosis and their potential promise as therapeutic targets to halt progression of this debilitating rheumatic disease. RECENT FINDINGS: Protein tyrosine phosphatases are emerging as important regulators of a multitude of signaling pathways and undergoing validation as molecular targets for cancer and other common diseases. Recent advances in drug discovery are paving the ways to develop new classes of tyrosine phosphatase modulators to treat human diseases. Although so far only few reports have focused on tyrosine phosphatases in systemic sclerosis, these enzymes play a role in multiple pathways relevant to disease pathogenesis. Further studies in this field are warranted to explore the potential of tyrosine phosphatases as drug targets for systemic sclerosis.
Asunto(s)
Terapia Molecular Dirigida/métodos , Proteínas Tirosina Fosfatasas/fisiología , Esclerodermia Sistémica/enzimología , Endotelio Vascular/fisiopatología , Inhibidores Enzimáticos/uso terapéutico , Fibrosis , Sustancias de Crecimiento/fisiología , Humanos , Proteínas Tirosina Fosfatasas/antagonistas & inhibidores , Receptores de Interleucina/inmunología , Esclerodermia Sistémica/tratamiento farmacológico , Esclerodermia Sistémica/inmunología , Transducción de Señal/inmunología , Investigación Biomédica Traslacional/métodosRESUMEN
The reproductive tract secretes bioactive molecules collectively known as embryokines that can regulate embryonic growth and development. In the present study we tested four growth factors expressed in the endometrium for their ability to modify the development of the bovine embryo to the blastocyst stage and alter the expression of genes found to be upregulated (bone morphogenetic protein 15 (BMP15) and keratin 8, type II (KRT8)) or downregulated (NADH dehydrogenase 1 (ND1) and S100 calcium binding protein A10 (S100A10)) in embryos competent to develop to term. Zygotes were treated at Day 5 with 0.01, 0.1 or 1.0nM growth factor. The highest concentration of activin A increased the percentage of putative zygotes that developed to the blastocyst stage. Connective tissue growth factor (CTGF) increased the number of cells in the inner cell mass (ICM), decreased the trophectoderm:ICM ratio and increased blastocyst expression of KRT8 and ND1. The lowest concentration of hepatocyte growth factor (HGF) reduced the percentage of putative zygotes becoming blastocysts. Teratocarcinoma-derived growth factor 1 increased total cell number at 0.01nM and expression of S100A10 at 1.0nM, but otherwise had no effects. Results confirm the prodevelopmental actions of activin A and indicate that CTGF may also function as an embryokine by regulating the number of ICM cells in the blastocyst and altering gene expression. Low concentrations of HGF were inhibitory to development.
Asunto(s)
Activinas/fisiología , Blastocisto/fisiología , Bovinos/embriología , Bovinos/fisiología , Factor de Crecimiento del Tejido Conjuntivo/fisiología , Desarrollo Embrionario/fisiología , Factor de Crecimiento de Hepatocito/fisiología , Activinas/farmacología , Animales , Blastocisto/efectos de los fármacos , Factor de Crecimiento del Tejido Conjuntivo/farmacología , Técnicas de Cultivo de Embriones/métodos , Técnicas de Cultivo de Embriones/veterinaria , Desarrollo Embrionario/efectos de los fármacos , Femenino , Sustancias de Crecimiento/farmacología , Sustancias de Crecimiento/fisiología , Factor de Crecimiento de Hepatocito/farmacología , EmbarazoRESUMEN
The term angiogenesis arose in the 18th century. Several studies over the next 100 years laid the groundwork for initial studies performed by the Folkman laboratory, which were at first met with some opposition. Once overcome, the angiogenesis field has flourished due to studies on tumor angiogenesis and various developmental models that can be genetically manipulated, including mice and zebrafish. In addition, new discoveries have been aided by the ability to isolate primary endothelial cells, which has allowed dissection of various steps within angiogenesis. This review will summarize the molecular events that control angiogenesis downstream of biochemical factors such as growth factors, cytokines, chemokines, hypoxia-inducible factors (HIFs), and lipids. These and other stimuli have been linked to regulation of junctional molecules and cell surface receptors. In addition, the contribution of cytoskeletal elements and regulatory proteins has revealed an intricate role for mobilization of actin, microtubules, and intermediate filaments in response to cues that activate the endothelium. Activating stimuli also affect various focal adhesion proteins, scaffold proteins, intracellular kinases, and second messengers. Finally, metalloproteinases, which facilitate matrix degradation and the formation of new blood vessels, are discussed, along with our knowledge of crosstalk between the various subclasses of these molecules throughout the text. Compr Physiol 8:153-235, 2018.
Asunto(s)
Neovascularización Patológica/fisiopatología , Animales , Citocinas/fisiología , Sustancias de Crecimiento/fisiología , Humanos , Factor 1 Inducible por Hipoxia/fisiología , Receptores de Citocinas/fisiología , Receptores de Factores de Crecimiento/fisiología , Esfingolípidos/fisiologíaRESUMEN
OBJECTIVE: The aim of this study was to investigate the effect of platelet-rich plasma (PRP) on the healing of colonic anastomosis in the presence of sepsis. MATERIALS AND METHOD: Fifty Wistar-albino male rats were used. Ten healthy rats were euthanized to prepare PRP, the rest were subjected to colonic anastomosis and randomly allocated into four groups of 10 rats each as anastomosis without PRP (C), without PRP in sepsis (SC), anastomosis with PRP (C-PRP), and with PRP in sepsis (S-PRP). Sepsis was induced by cecal ligation and puncture procedure. All animals were euthanized on postoperative day 7. The body weight change, anastomotic bursting pressure (ABP), tissue hydroxyproline (TH) and histopathological examination of each group were analyzed by using one-way analysis of variance (ANOWA) and Tukey's HSD post-hoc test to assess the differences between the groups. RESULTS: There was no statistical difference among the groups in terms of body weight changes. The ABP was measured at a mean value of 179.5 ± 10.3, 129.3 ± 14.2, 209 ± 14.4, and 167.5 ± 7.5 mm-Hg, in group C, SC, C-PRP, and S-PRP, respectively. The ABP and TH of C-PRP group was significantly higher than three groups (p < .05, for each comparison). In sepsis, PRP significantly raised the mean ABP and TH levels up to the levels of C group. Tissue regeneration was significant with increased collagen formation in C-PRP group than the other groups (p < .05). The healing effect of PRP in the presence of sepsis was significant than S-group (p < .05), while similar to C group (p = .181). CONCLUSION: PRP application to colonic anastomosis promotes the healing process in rats with intra-abdominal sepsis.
Asunto(s)
Anastomosis Quirúrgica , Colon/cirugía , Plasma Rico en Plaquetas/fisiología , Sepsis/cirugía , Cicatrización de Heridas/fisiología , Animales , Colon/patología , Modelos Animales de Enfermedad , Sustancias de Crecimiento/fisiología , Hidroxiprolina/metabolismo , Masculino , Ratas , Ratas Wistar , Sepsis/patologíaRESUMEN
Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl carboxylase in HCC cells, the 10 glutamic acid (Glu) residues in prothrombin precursor did not completely carboxylate to γ-carboxylated glutamic acid (Gla) residues, leaving some Glu residues remained in N-terminal domain. These prothrombin precursors with Glu residues are called DCPs. DCP displays insufficient coagulation activity. Since Liebman reported an elevated plasma DCP in patients with HCC, DCP has been used in the diagnosis of HCC. Recently, its biological malignant potential has been specified to describe DCP as an autologous growth factor to stimulate HCC growth and a paracrine factor to integrate HCC with vascular endothelial cells. DCP was found to stimulate HCC growth through activation of the DCP-Met-JAK1-STAT3 signaling pathway. DCP might increase HCC invasion and metastasis through activation of matrix metalloproteinase (MMPs) and the ERK1/2 MAPK signaling pathway. DCP has also been found to play a crucial role in the formation of angiogenesis. DCP could increase the angiogenic factors released from HCC and vascular endothelial cells. These effects of DCP in angiogenesis might be related to activation of the DCP-KDR-PLC-γ-MAPK signaling pathway. In this article, we summarized recent studies on DCP in biological roles related to cancer progression and angiogenesis in HCC.
Asunto(s)
Carcinoma Hepatocelular/fisiopatología , Sustancias de Crecimiento/fisiología , Neoplasias Hepáticas/fisiopatología , Precursores de Proteínas/fisiología , Protrombina/fisiología , Biomarcadores/química , Biomarcadores de Tumor , Carcinoma Hepatocelular/diagnóstico , Humanos , Neoplasias Hepáticas/diagnóstico , Estructura Molecular , Precursores de Proteínas/química , Protrombina/químicaRESUMEN
Injuries to the growth plate cartilage often lead to bony repair, resulting in bone growth defects such as limb length discrepancy and angulation deformity in children. Currently utilised corrective surgeries are highly invasive and limited in their effectiveness, and there are no known biological therapies to induce cartilage regeneration and prevent the undesirable bony repair. In the last 2 decades, studies have investigated the cellular and molecular events that lead to bony repair at the injured growth plate including the identification of the four phases of injury repair responses (inflammatory, fibrogenic, osteogenic and remodelling), the important role of inflammatory cytokine tumour necrosis factor alpha in regulating downstream repair responses, the role of chemotactic and mitogenic platelet-derived growth factor in the fibrogenic response, the involvement and roles of bone morphogenic protein and Wnt/B-catenin signalling pathways, as well as vascular endothelial growth factor-based angiogenesis during the osteogenic response. These new findings could potentially lead to identification of new targets for developing a future biological therapy. In addition, recent advances in cartilage tissue engineering highlight the promising potential for utilising multipotent mesenchymal stem cells (MSCs) for inducing regeneration of injured growth plate cartilage. This review aims to summarise current understanding of the mechanisms for growth plate injury repair and discuss some progress, potential and challenges of MSC-based therapies to induce growth plate cartilage regeneration in combination with chemotactic and chondrogenic growth factors and supporting scaffolds.
Asunto(s)
Fracturas de Salter-Harris , Animales , Desarrollo Óseo/fisiología , Regeneración Ósea/fisiología , Remodelación Ósea/fisiología , Tratamiento Basado en Trasplante de Células y Tejidos , Condrocitos/trasplante , Fibrosis , Placa de Crecimiento/patología , Placa de Crecimiento/fisiopatología , Sustancias de Crecimiento/fisiología , Humanos , Inflamación/patología , Inflamación/fisiopatología , Trasplante de Células Madre Mesenquimatosas , Osteogénesis/fisiología , Transducción de Señal , Ingeniería de TejidosRESUMEN
Recent pre-clinical and clinical research has provided evidence that cancer progression is driven not only by a tumour's underlying genetic alterations and paracrine interactions within the tumour microenvironment, but also by complex systemic processes. We review these emerging paradigms of cancer pathophysiology and discuss how a clearer understanding of systemic regulation of cancer progression could guide development of new therapeutic modalities and efforts to prevent disease relapse following initial diagnosis and treatment.
Asunto(s)
Metástasis de la Neoplasia/fisiopatología , Microambiente Tumoral/fisiología , Animales , Médula Ósea/patología , Médula Ósea/fisiopatología , Micropartículas Derivadas de Células/fisiología , Citocinas/fisiología , Progresión de la Enfermedad , Sustancias de Crecimiento/fisiología , Humanos , Modelos Biológicos , Metástasis de la Neoplasia/inmunología , Metástasis de la Neoplasia/patología , Neovascularización Patológica , Bazo/patología , Bazo/fisiopatología , Biología de Sistemas , Microambiente Tumoral/inmunologíaAsunto(s)
Placa de Crecimiento/fisiología , Animales , Desarrollo Óseo/fisiología , Enfermedades del Desarrollo Óseo/fisiopatología , Enfermedades del Desarrollo Óseo/terapia , Placa de Crecimiento/crecimiento & desarrollo , Placa de Crecimiento/fisiopatología , Sustancias de Crecimiento/fisiología , Humanos , Transducción de SeñalRESUMEN
Tooth eruption is of the utmost importance for the normal development of the dentition and the face. Since the 1980s, it has been known that the tooth germ itself is not essential for facilitating the processes that make tooth eruption possible. For that reason, recent research on the regulatory mechanisms of tooth eruption has focused mainly on the enamel organ and the dental follicle. Different regulatory mechanisms act on the occlusal and the apical sides of an erupting tooth. On the occlusal side osteoclast differentiation is stimulated. This leads to the development of an eruption canal, a process in which macrophages and matrix metalloproteases also play an important role. On the apical side the most important factors are the transcription factor RUNX2 and the bone morphogenic protein 2. They are responsible for the deposition of trabecular bone in that area. Many regulatory mechanisms which are involved in tooth eruption are also active in other developmental processes. This explains that certain syndromes can also have an effect on the tooth eruption process.
Asunto(s)
Sustancias de Crecimiento/fisiología , Osteoclastos/fisiología , Erupción Dental/fisiología , Niño , Preescolar , Enfermedades Genéticas Congénitas/fisiopatología , Humanos , Transducción de Señal , Erupción Dental/genética , Germen Dentario/fisiología , Raíz del Diente/crecimiento & desarrollo , Factores de Transcripción/fisiologíaRESUMEN
UNLABELLED: Natural amino acid substitution by single-site nucleotide polymorphism can become a valuable tool for structure-activity correlations, especially if evidence for association to disease parameters exists. Focusing on the F19Y change in human galectin-8, connected clinically to rheumatoid arthritis, we here initiate the study of consequences of a single-site substitution in the carbohydrate recognition domain of this family of cellular effectors. We apply a strategically combined set of structural and cell biological techniques for comparing properties of the wild-type and variant proteins. The overall hydrodynamic behavior of the full-length protein and of the separate N-domain is not noticeably altered, but displacements in the F0 ß-strand of the ß-sandwich fold in the N-domain are induced, as evidenced by protein crystallography. Analysis of thermal stability by circular dichroism spectroscopy revealed perceptible differences for the full-length proteins, pointing to an impact of the substitution beyond the N-domain. In addition, small differences in thermodynamic parameters of carbohydrate binding are detected. On the level of two types of tumor cells, characteristics of binding appeared rather similar. In further comparison of the influence on proliferation, the variant proved to be more active as growth regulator in the six tested lines of neuroblastoma, erythroleukemia and colon adenocarcinoma. The seemingly subtle structural change identified here thus has functional implications in vitro, encouraging further analysis in autoimmune regulation and, in a broad context, in work with other natural single-site variants, using the documented combined strategy. DATABASE: The atomic coordinates and structure factors (codes 4BMB, 4BME) have been deposited in the Protein Data Bank.
Asunto(s)
Galectinas/química , Galectinas/genética , Polimorfismo de Nucleótido Simple , Sustitución de Aminoácidos , Línea Celular Tumoral , Dicroismo Circular , Cristalografía por Rayos X , Galectinas/fisiología , Sustancias de Crecimiento/química , Sustancias de Crecimiento/genética , Sustancias de Crecimiento/fisiología , Humanos , Hidrodinámica , Lactosa/metabolismo , Ligandos , Modelos Moleculares , Estabilidad Proteica , Estructura Cuaternaria de Proteína , Estructura Terciaria de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , TermodinámicaRESUMEN
Current treatment options for ischemia include percutaneous interventions, surgical bypass or pharmacological interventions aimed at slowing the progression of vascular disease. Unfortunately, while each of these treatment modalities provides some benefit for patients in the short-term, many patients have resistant or recurrent disease that is poorly managed by these therapies. A highly appealing strategy for treating ischemic disease is to stimulate the revascularization of the tissue to restore blood flow. While many techniques have been explored in this regard, clinically effective angiogenic therapies remain elusive. Here, we hypothesized that the presence of co-morbid disease states inherently alters the ability of the body to respond to angiogenic therapies. Using a mouse model of diabetes and obesity, we examined alterations in the major components for the signaling pathways for FGF-2, VEGF-A and PDGF under normal and high fat dietary conditions. In skeletal muscle, a high fat diet increased levels of growth factor receptors and co-receptors including syndecan-1, syndecan-4 and PDGFR-α in wild-type mice. These increases did not occur in Ob/Ob mice on a high fat diet and there was a significant decrease in protein levels for neuropilin-1 and heparanase in these mice. With the aim of increasing growth factor effectiveness in the context of disease, we examined whether local treatment with alginate gel-delivered FGF-2 and syndecan-4 proteoliposomes could overcome the growth factor resistance in these mice. This treatment enhanced the formation of new blood vessels in Ob/Ob mice by 6 fold in comparison to FGF-2 delivered alone. Our studies support that disease states cause a profound shift in growth factor signaling pathways and that co-receptor-based therapies have potential to overcome growth factor resistance in the context of disease.
Asunto(s)
Sustancias de Crecimiento/fisiología , Liposomas , Neovascularización Fisiológica , Receptores de Superficie Celular/fisiología , Animales , Modelos Animales de Enfermedad , Regulación de la Expresión Génica , Ratones , Ratones Endogámicos C57BL , Músculo Esquelético/metabolismo , Receptores de Superficie Celular/genética , Proteínas Recombinantes/metabolismoRESUMEN
La endodoncia regenerativa desarrolla técnicas basadas en ingeniería de tejidos para reponer tejidos perdidos. Con el desarrollo del conocimiento actual de la biología molecular, la microbiología y la genética, entre otras disciplinas, estamos en condiciones de introducirnos en el conocimiento de las cascadas de señales intracelulares desencadenadas por los sistemas complejos autoorganizados en sus procesos de autoreparación. Esto nos permite definir los pasos que debemos efectuar para la regeneración ad integrum de los tejidos que conforman el sistema de inserción dental
Asunto(s)
Humanos , Ápice del Diente/fisiología , Enfermedades Periapicales/terapia , Regeneración , Matriz Extracelular/fisiología , Mesodermo/fisiología , Células Madre , Sustancias de Crecimiento/fisiología , Ingeniería de TejidosRESUMEN
Growth factors and nutrients regulate the mTORC1 [mammalian (or mechanistic) target of rapamycin complex 1] by different mechanisms. The players that link growth factors and mTORC1 activation have been known for several years and mouse models have validated its relevance for human physiology and disease. In contrast with the picture for growth factor signalling, the means by which nutrient availability leads to mTORC1 activation have remained elusive until recently, with the discovery of the Rag GTPases upstream of mTORC1. The Rag GTPases recruit mTORC1 to the outer lysosomal surface, where growth factor signalling and nutrient signalling converge on mTORC1 activation. A mouse model of constitutive RagA activity has revealed qualitative differences between growth-factor- and nutrient-dependent regulation of mTORC1. Regulation of mTORC1 activity by the Rag GTPases in vivo is key for enduring early neonatal starvation, showing its importance for mammalian physiology.
Asunto(s)
Sustancias de Crecimiento/fisiología , Complejos Multiproteicos/metabolismo , Serina-Treonina Quinasas TOR/metabolismo , Animales , Animales Recién Nacidos , Humanos , Diana Mecanicista del Complejo 1 de la Rapamicina , Ratones , Modelos MolecularesAsunto(s)
Distinciones y Premios , Gastroenterología/historia , Animales , Citocinas/historia , Citocinas/fisiología , Europa (Continente) , Terapia Genética/historia , Sustancias de Crecimiento/historia , Sustancias de Crecimiento/fisiología , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Hígado/fisiopatología , Cirrosis Hepática Biliar/etiología , Cirrosis Hepática Biliar/historia , Sociedades Médicas , EspañaRESUMEN
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely consumed by athletes worldwide, despite growing evidence for a negative influence on the adaptation of skeletal muscle to exercise, at least in young healthy individuals. This review focuses on the potential of NSAIDs to alter the activity of satellite cells, the muscle stem cell responsible for repair and maintenance of skeletal muscle. The signaling pathways that are potentially modified by NSAID exposure are also considered. Growth factors as well as inflammatory cells and connective tissue appear to be key factors in the response of muscle under conditions where cyclooxygenase and prostaglandin activity are blocked through NSAID ingestion or infusion. Discrepancies in the literature regarding the response of young and old individuals are addressed, where it appears that the elderly may benefit from NSAID ingestion, although this clearly requires further study. The long-term implications for the muscle of the apparent inhibitory effect of NSAIDs on satellite cells in younger individuals are not clear, and it is possible these may first become apparent with chronic use in athletes training at a high level or with advancing age. Reports of the potential for NSAIDs to alter prostaglandin and growth factor signaling provide a basis for further study of the mechanism of NSAID action on satellite cells.
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Células Satélite del Músculo Esquelético/efectos de los fármacos , Adaptación Fisiológica/efectos de los fármacos , Animales , Ejercicio Físico/fisiología , Sustancias de Crecimiento/fisiología , Humanos , Hipertrofia/fisiopatología , Proteínas Musculares/biosíntesis , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/lesiones , Músculo Esquelético/fisiopatología , Prostaglandinas/fisiología , Entrenamiento de Fuerza , Células Satélite del Músculo Esquelético/fisiología , Transducción de Señal/efectos de los fármacosRESUMEN
The aim of this pilot study was to present a novel technique for the management of the Schneiderian membrane during maxillary sinus lift surgery using plasma rich in growth factors (PRGF). Eight maxillary sinuses were augmented in 8 patients. Two small perforations of the Schneiderian membrane occurred during the lifting procedure, which were solved using the PRGF clot before grafting the site with PRGF and anorganic bovine bone. With the exception of 1 patient who experienced pain following an acute sinus infection after 3 days of uneventful healing, the patients' postoperative quality of life was generally good. The most common complication (50% of cases) was hematoma, which disappeared after 1 week. Despite the limitations of this study concerning the sample size and the study design, the use of PRGF may be helpful in reducing complications following sinus lift surgery. More well-designed studies, with larger sample size, are needed to validate this protocol.
Asunto(s)
Pérdida de Hueso Alveolar/cirugía , Apósitos Biológicos , Sustancias de Crecimiento/administración & dosificación , Mucosa Nasal/lesiones , Plasma Rico en Plaquetas/fisiología , Elevación del Piso del Seno Maxilar/métodos , Adulto , Anciano , Pérdida de Hueso Alveolar/terapia , Aumento de la Cresta Alveolar/métodos , Femenino , Sustancias de Crecimiento/aislamiento & purificación , Sustancias de Crecimiento/fisiología , Humanos , Péptidos y Proteínas de Señalización Intercelular/administración & dosificación , Péptidos y Proteínas de Señalización Intercelular/aislamiento & purificación , Arcada Edéntula/rehabilitación , Arcada Edéntula/cirugía , Masculino , Maxilar/cirugía , Seno Maxilar/cirugía , Persona de Mediana Edad , Mucosa Nasal/fisiología , Procedimientos Quirúrgicos Preprotésicos Orales/métodos , Proyectos Piloto , Plasma Rico en Plaquetas/química , Estudios Prospectivos , Resultado del TratamientoRESUMEN
Epidemiological data have demonstrated that the prevalence of either obesity or hepatocellular carcinoma (HCC) is increasing worldwide during past decades, and obesity has been unequivocally shown to be a risk factor for HCC. It has been reported that a significant proportion of HCC in obesity develops in cryptogenic cirrhosis, which is largely associated with the progression of nonalcoholic fatty liver disease, especially nonalcoholic steatohepatitis. Since the HCC is a highly malignant tumor with a poor prognosis, a better understanding of the molecular mechanisms may help researchers to explore new approaches for preventing and treating the obesity-related HCC, and thereby facilitating a substantial reduction of morbidity and mortality. In this article, we reviewed the mechanisms underlying the relationship between obesity and HCC, with an emphasis on the roles of insulin/insulin-like growth factor axis, adipose tissue derived hormones, oxidative stress, and liver stem cells. In addition, we will discuss the impact of life-style modification on obesity-related HCC.